MARKET

NXTC

NXTC

NextCure
NASDAQ

Real-time Quotes | Nasdaq Last Sale

35.99
+1.00
+2.86%
Opening 10:54 04/02 EDT
OPEN
34.41
PREV CLOSE
34.99
HIGH
36.72
LOW
34.41
VOLUME
10.52K
TURNOVER
--
52 WEEK HIGH
109.00
52 WEEK LOW
13.86
MARKET CAP
990.07M
P/E (TTM)
-21.0517
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average NXTC stock price target is 69.25 with a high estimate of 87.00 and a low estimate of 55.00.

EPS

NXTC News

More
  • NextCure Announces Appointment of Veteran Oncology Executive Garry Nicholson to its Board of Directors
  • GlobeNewswire · 3d ago
  • Why You Shouldn't Bet Against NextCure (NXTC) Stock
  • Zacks · 03/26 13:52
  • Blair likes Incyte in premarket analyst action
  • Seeking Alpha - Article · 03/24 11:53
  • NextCure EPS misses by $0.12, beats on revenue
  • seekingalpha · 03/13 02:06

Industry

Pharmaceuticals
+0.80%
Pharmaceuticals & Medical Research
+0.98%

Hot Stocks

Symbol
Price
%Change

About NXTC

Nextcure Inc. is a clinical-stage biopharmaceutical company, which is focused on discovering and developing immunomedicines to treat cancer and other immune-related diseases. The Company uses its functional integrated nextcure discovery in immune oncology (FIND-IO) technology to functional screening approaches for the identification of targets from multiple therapeutic areas, including autoimmunity and neurology, enabling immunomedicine to treat unmet medical needs. Its product pipelines include NC318, a immunotherapeutic against a immunomodulatory target found on a restricted set of myeloid and tumor cells, and NC410, a immunomedicine designed to block an immune regulator expressed on T cells and suppressive antigen-presenting cell populations, including dendritic cell subpopulations.
More

Webull offers kinds of NextCure Inc stock information, including NASDAQ:NXTC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NXTC stock news, and many more online research tools to help you make informed decisions.